Schisandrin (Wuweizi alcohol-A) is a compound with anti-asthmatic, anti-cancer, and anti-inflammatory effects.

Schisandrin C epoxide is a natural product for research related to life sciences. The catalog number is TN4958 and the CAS number is 81345-36-0.

Schisandrin C (Wuweizisu-C) is a phytochemical lignan isolated from Schizandra chinensis Baill; shows anticancer-effects in human leukemia U937 cells.

Schisandrin B (Schisandrin B (Sch B)) has an antioxidant effect on rodent liver and heart.

1. Schisandrol B (Besigomsin) may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-κB and MAPKs signaling pathways. 2. Schisandrol B has anti-inflammatory property, potentially result from the inhibition of COX-2, iNOS, IL-6, TNF-α and NO through the down-regulation of RIP2 and NF-κB activation. 3. Schisandrol B induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal transduction pathway. 4. Schisandrol B significantly inhibits cell proliferation in a dose-dependent manner, due to cell cycle arrest in the G1 phase with the downregulation of cyclin D1 expression and Retinoblastoma (RB) phosphorylation.

Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.

Schisandrin E (compound 5), a lignan extractible from Schisandra chinensis [1], exhibits pharmacological properties.

Schisandrin C, a lignan extracted from the fruit of Schisandra chinensis, exhibits antihepatitis, antitumor, and anti-HIV-1 activities [1].

Changnanic acid (schisandrin), a triterpene compound, has demonstrated potential anti-tumor properties, exhibiting moderate cytotoxicity against human tumor cell lines Bel-7402 and MCF-7 with IC50s of 100 μM, and against HL-60 with an IC50 of 50.51 μM [1].

Schisandrin A, a primary active component extracted from the traditional Eastern medicine Schisandra chinensis, inhibits CYP3A activity, with an IC50 of 6.60 μM and a Ki of 5.83 μM.